Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Emtenani
S. Emtenani
University of Lübeck
Autoantibody
Medicine
Bullous pemphigoid
Pathology
Low molecular weight heparin
3
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification of novel therapeutic targets for blocking acantholysis in pemphigus.
2020
British Journal of Pharmacology
Imke A. K. Burmester
Sarah Flaswinkel
Clara-Sophie Thies
Anika Kasprick
Mayumi Kamaguchi
Valéria Bumiller-Bini
S. Emtenani
Nick Feldmann
Khalaf Kridin
Enno Schmidt
Nina van Beek
Detlef Zillikens
Christoph M. Hammers
Jennifer E. Hundt
Ralf Ludwig
Show All
Source
Cite
Save
Citations (3)
BP180-specific IgG is associated with skin adverse events, therapy response and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
2019
Journal of The American Academy of Dermatology
Omar Hasan-Ali
David Bomze
Sandra Ring
Fiamma Berner
Mirjam Fässler
Stefan Diem
Marie Therese Abdou
Christoph M. Hammers
S. Emtenani
Anne Braun
Antonio Cozzio
Bernhard Mani
Wolfram Jochum
Enno Schmidt
Detlef Zillikens
Christian D. Sadik
Lukas Flatz
Show All
Source
Cite
Save
Citations (18)
Bullous pemphigoid autoantibody‐mediated complement fixation is abolished by the low‐molecular‐weight heparin tinzaparin sodium
2019
British Journal of Dermatology
A. Gutjahr
F. Heck
S. Emtenani
A.‐K. Hammers
Jennifer E. Hundt
Philip Muck
Don L. Siegel
Enno Schmidt
John R. Stanley
Detlef Zillikens
Christoph M. Hammers
Show All
Source
Cite
Save
Citations (4)
1